Latest filing published 07 Aug 2026 for Jazz Pharmaceuticals plc. Read the official filing
No signal scores available.
All filings by Patrick Kennedy on record concern Jazz Pharmaceuticals plc. In total, 4 filings cover trades dated from 1 March 2024 to 5 August 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 7 August 2026: a share grant, in Jazz Pharmaceuticals plc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations